CIDRAP newsletters options
In the past week, new daily COVID-19 cases fell 20%, deaths dropped 0.8%, and hospitalizations fell 8.9%.
Delta variant transmission is complicating plans for easing COVID-19 restrictions in some Asian nations.
An analysis of US health insurance data found that post-discharge prophylactic antibiotics are commonly prescribed after mastectomy, but provide only a small reduction in surgical-site infections (SSIs), researchers reported today in Infection Control & Hospital Epidemiology.
Taking anticoagulants before contracting COVID-19 is associated with a 43% lower risk for hospital admission, and receiving anticoagulants while in the hospital is tied to a lower death rate, according to a study published late last week in EClinicalMedicine.
Demand for the treatment has been skyrocketing in US hot spots such as Florida.
"I think it's fascinating that something like telemedicine ... actually worsened those disparities."
CDC director explains her rationale for offering third doses to frontline and essential workers.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Of 1,061 people who were hesitant about receiving the COVID-19 vaccine at the end of 2020, 32% were at least partially vaccinated by spring 2021, and 37% said they were likely to be, according to a research letter published today in JAMA Network Open.
Point-of-care testing for C-reactive protein (CRP) in nursing home residents with suspected lower respiratory tract infections resulted in a large reduction in antibiotic prescribing at initial consultation, according to the results of a cluster-randomized trial published this week in BMJ.
Sweden pledges $243 million more, and other dose donations come from Japan, Italy, Spain, and Denmark.
Weekly COVID-19 testing of asymptomatic students and staff in Nebraska roughly doubled the detection rate.
CDC advisers approve Pfizer vaccine booster doses for seniors and for at-risk adults.
"Our findings suggest a potential risk of cross-border spread across Africa."
Multisystem inflammatory syndrome in adults (MIS-A) is a rare but severe hyperinflammatory condition that begins roughly 4 weeks after COVID-19 symptom onset and likely results from an outsized immune response, concludes a systematic review yesterday in JAMA Network Open.
A review of national prescription drug data finds a mixed picture on US outpatient antibiotic use in 2020, researchers reported yesterday in JAMA Network Open.
Effectiveness remained high despite underlying health conditions, frontline status.
Despite the major new pledge from the US, the world needs 2 billion doses to meet global vaccination goals.
As ACIP deliberates, other data still show racial gaps among vaccination rates.
A nationwide cohort study in Sweden found a twofold increased risk of acute liver injuries (ALIs) associated with oral fluoroquinolones in the first 2 months after starting treatment, researchers reported this week in Clinical Infectious Diseases.
